{"Although": [0], "several": [1], "clinical": [2], "trials": [3], "are": [4], "now": [5], "underway": [6], "to": [7, 14, 22, 34, 53, 63], "test": [8], "possible": [9, 79], "therapies,": [10], "the": [11, 15, 45], "worldwide": [12], "response": [13], "COVID-19": [16], "outbreak": [17], "has": [18], "been": [19], "largely": [20], "limited": [21], "monitoring/containment.": [23], "We": [24], "report": [25], "here": [26], "that": [27], "Ivermectin,": [28], "an": [29, 42], "FDA-approved": [30], "anti-parasitic": [31], "previously": [32], "shown": [33], "have": [35], "broad-spectrum": [36], "anti-viral": [37], "activity": [38], "in": [39, 67, 81], "vitro,": [40], "is": [41], "inhibitor": [43], "of": [44], "causative": [46], "virus": [47], "(SARS-CoV-2),": [48], "with": [49, 60], "a": [50], "single": [51], "addition": [52], "Vero-hSLAM": [54], "cells": [55], "2": [56], "h": [57], "post": [58], "infection": [59], "SARS-CoV-2": [61], "able": [62], "effect": [64], "~5000-fold": [65], "reduction": [66], "viral": [68], "RNA": [69], "at": [70], "48": [71], "h.": [72], "Ivermectin": [73], "therefore": [74], "warrants": [75], "further": [76], "investigation": [77], "for": [78], "benefits": [80], "humans.": [82]}